PureHealth Sells Abu Dhabi Stem Cells Centre And Yas Clinic Group

PureHealth, the Middle East's largest healthcare platform, has successfully sold its entire equity interest in Abu Dhabi Stem Cells Centre (ADSCC) and Yas Clinic Group (Yas Clinic). This decision aligns with PureHealth's broader strategy to streamline operations, reallocate resources towards profitable business activities, and extract synergies across the group.

Following the sale, PureHealth will concentrate on advancing specialised healthcare services previously offered at ADSCC and Yas Clinic at Sheikh Shakbout Medical City (SSMC). The company recently announced the full integration of SSMC, which is the UAE's premier healthcare complex.

SSMC boasts state-of-the-art stem cell therapy facilities and world-class clinical expertise, offering some of the most advanced specialised services in the region. These services will now be integrated and further developed at SSMC, complementing the overall group operations.

SSMC covers a built-up area of over 300,000 square metres and features 732 beds. It plays a crucial role in handling a significant annual patient volume, with around 600,000 interactions. This includes more than 445,000 outpatient visits, over 130,000 emergency cases, and over 27,000 inpatient admissions.

SSMC operates 162 outpatient rooms and is supported by a team of more than 490 physicians across 46 service lines and 12 clinical departments, along with over 1,500 nurses.